callToll Free(US/Canada):+1 866 658 6826 |+1 425 320 4776 |+44 1865 60 0662 |+91 9096278110 |emailinfo@blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Mrna Vaccine And Therapeutics Market
Inquire Before Buying Request for Sample

Mrna Vaccine And Therapeutics Market

Home Healthcare And Pharmaceutical Mrna Vaccine And Therapeutics Market

mRNA Vaccine and Therapeutics Market, By Product Type (mRNA Vaccines, mRNA Therapeutics); By Route of Administration (Intramuscular, Intravenous, Others); By Application (Cancer, Genetic Disorders, Infectious Diseases, Cardiovascular Disorders, Others); By End User (Hospitals & Clinics, Research Organizations, Pharmaceutical & Biotechnology Companies, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa), Global Trend Analysis, Competitive Landscape & Forecast, 2019–2031

  • Published Date: July 2025
  • Report ID: BWC25374
  • Available Format: PDF
  • Page: 499

Report Overview

The rising demand for gene and cell therapies, increasing approvals for viral vector-based drugs and vaccines, and an increasing number of clinical trials are expected to boost the growth of Global mRNA Vaccine and Therapeutics Market during the forecast period between 2025 and 2031.

Global mRNA Vaccine and Therapeutics Market - Industry Trends & Forecast Report, 2031

Global mRNA Vaccine and Therapeutics Market size was estimated to be worth USD 13.36 billion in 2024. During the forecast period between 2025 and 2031, Global mRNA Vaccine and Therapeutics Market size is projected to grow at a robust CAGR of 15.5% reaching a value of USD 36.64 billion by 2031. Major growth factors for Global mRNA Vaccine and Therapeutics Market include the increasing focus on mRNA-based treatments for chronic diseases due to their enhanced safety, production efficiency, and immunological advantages over traditional DNA vaccines. These therapeutics are lab-generated and work by triggering immune responses through the production of viral antigens within the body, boosting both B- and T-cell activity. The urgent global demand for effective COVID-19 vaccines has accelerated mRNA research and development, prompting pharmaceutical companies to prioritize safe and effective mRNA-based solutions. Moreover, the emergence of new viral strains has led regulatory authorities to fast-track approvals through emergency and conditional authorizations, further driving market expansion.

mRNA Vaccine and Therapeutics Market

mRNA Vaccine and Therapeutics – Overview

mRNA vaccines and therapeutics are advanced biomedical technologies that use messenger RNA to instruct cells to produce specific proteins that trigger immune responses or treat diseases. Unlike traditional vaccines, mRNA-based products do not use live viruses; instead, they deliver synthetic mRNA sequences that encode antigens or therapeutic proteins. Once inside the body, cells translate the mRNA into proteins that help the immune system recognize and fight pathogens or correct underlying genetic conditions. These solutions offer advantages such as rapid development, high safety profiles, and strong immunogenicity, making them valuable in combating infectious diseases, cancers, and genetic disorders.

Global mRNA Vaccine and Therapeutics Market

Growth Drivers

Rising Adoption of mRNA Technology

The rising adoption of mRNA technology is significantly accelerating the growth of the global mRNA vaccine and therapeutics market. The urgent demand for COVID-19 vaccines has propelled the widespread use of mRNA platforms, leading regulatory bodies like the FDA and EMA to expedite approval processes through emergency use and conditional marketing authorizations. This has enabled faster market access and large-scale deployment of mRNA-based vaccines globally. Beyond pandemic response, mRNA technology is gaining prominence in diverse applications such as cancer immunotherapy, gene editing, protein replacement, and vaccines for infectious diseases. Its advantages, including rapid development, high safety, scalability, and adaptability to emerging viral strains, make it a highly preferred platform in modern therapeutics. Additionally, the integration of artificial intelligence is further enhancing vaccine research by streamlining antigen selection, epitope prediction, and immunogen design, thereby reducing time and cost while improving efficacy. The ability of mRNA to trigger targeted immune responses by delivering genetic instructions that enable the body to produce specific proteins or antigens underlines its vast potential across multiple therapeutic areas. As pharmaceutical companies and research institutions continue to expand clinical applications and invest heavily in innovation, the global mRNA vaccine and therapeutics market is set to witness sustained growth driven by the rising adoption of this transformative technology.

Challenges

Rising Production Costs

Increasing production and procurement costs of mRNA-based vaccines are emerging as a key restraint to the growth of the global mRNA vaccine and therapeutics market. While these vaccines have gained widespread recognition for their high efficacy and safety, especially during the COVID-19 pandemic, their affordability remains a significant concern for developing economies. For example, the average cost of Moderna's mRNA-1273 vaccine ranges from USD 11 to USD 13 per dose, while Pfizer-BioNTech’s BNT162b2 vaccine is priced between USD 8 and USD 10 per dose. Given that most mRNA vaccines require two doses per individual, the overall cost per patient becomes substantially high. This elevated pricing poses financial challenges for governments in low- and middle-income countries, limiting their ability to procure sufficient quantities for mass immunization. As a result, the high cost of production and distribution continues to hinder the widespread adoption of mRNA vaccines in emerging markets, thereby restraining the overall market growth.

Impact of Escalating Geopolitical Tensions on Global mRNA Vaccine and Therapeutics Market

Escalating geopolitical tensions could significantly impact the growth of Global mRNA Vaccine and Therapeutics Market. Such conflicts often disrupt global supply chains, affecting the availability of raw materials and specialized components required for mRNA vaccine production. Trade restrictions, sanctions, and border closures can delay manufacturing timelines and increase production costs. Additionally, political instability may shift government funding priorities away from healthcare innovation, slowing down research and development efforts. Uncertainty in international relations can also hinder global collaborations and regulatory harmonization, both of which are vital for clinical trials and distribution. These factors collectively pose risks to market expansion and accessibility worldwide.

Global mRNA Vaccine and Therapeutics Market

Segmental Coverage

Global mRNA Vaccine and Therapeutics Market – By Product Type

Based on product type, Global mRNA Vaccine and Therapeutics Market is bifurcated into mRNA Vaccines and mRNA Therapeutics segments.

Global mRNA Vaccine and Therapeutics Market – By Route of Administration

Global mRNA Vaccine and Therapeutics Market by route of administration is divided into Intramuscular, Intravenous, and other routes of administration segments. The intravenous segment holds a highest share in Global mRNA Vaccine and Therapeutics Market by route of administration. The dominance is driven by the effectiveness and precision offered by IV infusion in delivering mRNA vaccines and therapeutics directly into the bloodstream. This method enhances vaccine efficiency by allowing rapid access to lymphoid organs and immune cells, ensuring a stronger immune response. Intravenous administration is favored in clinical settings due to its speed, controlled dosage, extended systemic presence, and improved patient outcomes. Its advantages in managing cardiovascular conditions and reducing patient anxiety further support its widespread adoption, contributing significantly to market growth.

mRNA Vaccine and Therapeutics Market Size

Global mRNA Vaccine and Therapeutics Market – By Application

On the basis of application, Global mRNA Vaccine and Therapeutics Market is divided into Cancer, Genetic Disorders, Infectious Diseases, Cardiovascular Disorders, and other applications segments. The infectious diseases segment holds the highest share in Global mRNA Vaccine and Therapeutics Market by application. It is driven primarily by the high demand for COVID-19 treatments. The widespread adoption of mRNA-based vaccines and the growing pipeline of clinical candidates targeting various infectious diseases continue to support this dominance. Notable regulatory approvals, such as the FDA’s emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine in individuals aged 16 and above, and the 2023 approval of the updated COMIRNATY formulation for those 12 and older, further strengthen market growth. These developments highlight the expanding role of mRNA technology in infectious disease management.

Global mRNA Vaccine and Therapeutics Market – By End User

Based on end user, Global mRNA Vaccine and Therapeutics Market is segmented into Hospitals & Clinics, Research Organizations, Pharmaceutical & Biotechnology Companies, and other end users. The hospitals & clinics segment holds the largest share in Global mRNA Vaccine and Therapeutics Market by end user. The dominance is attributed to the widespread use of mRNA vaccines and therapeutics in clinical settings due to their rapid development, efficient delivery, and high safety profile. Unlike traditional vaccines, mRNA vaccines can be manufactured quickly with minimal platform adjustments and offer strong protection against various infectious diseases. Their therapeutic potential extends to treating cardiovascular, cerebrovascular, cancer, metabolic, and genetic conditions. The ease of design, fast expression, and low risk of genomic integration make them ideal for hospital and clinical use, driving segment growth.

Global mRNA Vaccine and Therapeutics Market – By Region

The in-depth research report on Global mRNA Vaccine and Therapeutics Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America holds the highest share in Global mRNA Vaccine and Therapeutics and is expected to maintain its dominance during the forecast period. The leadership is driven by strong contributions from United States and Canada, with United States at the forefront due to robust funding for mRNA vaccine development, a growing pipeline of therapeutic candidates, and the presence of both established and emerging pharmaceutical companies. The region benefits from advanced manufacturing infrastructure, including ultracold supply chains, and rising public awareness of mRNA technologies. Key players like Moderna and partnerships such as the one with Catalent for large-scale production have strengthened the regional market. Additional investments from organizations like CEPI and active involvement of companies such as Translate Bio and Arcturus Therapeutics are further fueling growth, ensuring North America’s continued dominance in the global mRNA vaccine and therapeutics landscape.

mRNA Vaccine and Therapeutics Market Share

Competitive Landscape

Global mRNA Vaccine and Therapeutics Market is highly competitive, as a number of companies are competing to gain a significant market share. Key players in the market include Sanofi, GSK Plc., AstraZeneca, CureVac N.V., Moderna Inc., Arcturus Therapeutics, BioNTech SE, Pfizer Inc., Daiichi Sankyo Company, Silence Therapeutics, Ethris GmbH, Panthera Therapeutics GmbH, Argos Therapeutics Inc., Gennova Biopharmaceuticals Ltd, and Providence Therapeutics. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In January 2025 - Arcturus Therapeutics Holdings Inc., a commercial mRNA-focused biopharmaceutical company, announced the development of LUNAR-H5N1, a self-amplifying mRNA vaccine designed to provide active immunization against H5N1-related pandemic influenza.

  • In January 2025 - Esphera Synbio, a pre-clinical synthetic biology firm, launched a new initiative aimed at enhancing the effectiveness of mRNA vaccines.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2024

Base Year – 2024

Estimated Year – 2025

Forecast Period – 2025–2031

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Product Type, Route of Administration, Application, End User, Region

Key Players

Sanofi, GSK Plc., AstraZeneca, CureVac N.V., Moderna Inc., Arcturus Therapeutics, BioNTech SE, Pfizer Inc., Daiichi Sankyo Company, Silence Therapeutics, Ethris GmbH, Panthera Therapeutics GmbH, Argos Therapeutics Inc., Gennova Biopharmaceuticals Ltd, Providence Therapeutics

 

By Product Type

  • mRNA Vaccines

  • mRNA Therapeutics

By Route of Administration

  • Intramuscular

  • Intravenous

  • Others

By Application

  • Cancer

  • Genetic Disorders

  • Infectious Diseases

  • Cardiovascular Disorders

  • Others

By End User

  • Hospitals & Clinics

  • Research Organizations

  • Pharmaceutical & Biotechnology Companies

  • Others

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America (LATAM)

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. mRNA Vaccine and Therapeutics Market Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global mRNA Vaccine and Therapeutics Market Insights
    1. End User Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Growing Demand for Personalized Medicine & Precision Therapies
        2. Rising Adoption of mRNA Technology
        3. Increasing Government Investments & Public-Private Partnerships
      2. Restraints
        1. Rising Production Costs
        2. Increasing Dependency on Cold Chain Logistics
      3. Opportunities
        1. Advancements in AI & Synthetic Biology
        2. Growing Application of mRNA in Cancer Immunotherapy & Genetic Disease Treatment
      4. Challenges
        1. Increasing Competition from Alternative Vaccines
        2. Regulatory Uncertainty
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global mRNA Vaccine and Therapeutics Market: Marketing Strategies
  5. Global mRNA Vaccine and Therapeutics Market: Pricing Analysis
  6. Global mRNA Vaccine and Therapeutics Market: Geography Analysis
    1. Global mRNA Vaccine and Therapeutics Market, Geographical Analysis, 2024
    2. Global mRNA Vaccine and Therapeutics, Market Attractiveness Analysis, 2024–2031
  7. Global mRNA Vaccine and Therapeutics Market Overview
    1. Market Size & Forecast, 2019–2031
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product Type
        1. mRNA Vaccines
        2. mRNA Therapeutics
      2. By Route of Administration
        1. Intramuscular
        2. Intravenous
        3. Others
      3. By Application
        1. Cancer
        2. Genetic Disorders
        3. Infectious Diseases
        4. Cardiovascular Disorders
        5. Others
      4. By End User
        1. Hospitals & Clinics
        2. Research Organizations
        3. Pharmaceutical & Biotechnology Companies
        4. Others
      5. By Region
        1. North America
        2. Europe
        3. Asia Pacific
        4. Latin America
        5. Middle East and Africa
  8. North America mRNA Vaccine and Therapeutics Market
    1. Market Size & Forecast, 2019–2031
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product Type
      2. By Route of Administration
      3. By Application
      4. By End User
      5. By Country
        1. United States
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        2. Canada
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
  9. Europe mRNA Vaccine and Therapeutics Market
    1. Market Size & Forecast, 2019–2031
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product Type
      2. By Route of Administration
      3. By Application
      4. By End User
      5. By Country
        1. Germany
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        2. United Kingdom
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        3. Italy
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        4. France
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        5. Spain
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        6. Belgium
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        7. Russia
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        8. The Netherlands
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        9. Rest of Europe
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
  10. Asia Pacific mRNA Vaccine and Therapeutics Market
    1. Market Size & Forecast, 2019–2031
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product Type
      2. By Route of Administration
      3. By Application
      4. By End User
      5. By Country
        1. China
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        2. India
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        3. Japan
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        4. South Korea
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        5. Australia & New Zealand
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        6. Indonesia
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        7. Malaysia
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        8. Singapore
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        9. Vietnam
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        10. Rest of APAC
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
  11. Latin America mRNA Vaccine and Therapeutics Market
    1. Market Size & Forecast, 2019–2031
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product Type
      2. By Route of Administration
      3. By Application
      4. By End User
      5. By Country
        1. Brazil
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        2. Mexico
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        3. Argentina
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        4. Peru
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        5. Rest of LATAM
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
  12. Middle East & Africa mRNA Vaccine and Therapeutics Market
    1. Market Size & Forecast, 2019–2031
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product Type
      2. By Route of Administration
      3. By Application
      4. By End User
      5. By Country
        1. Saudi Arabia
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        2. UAE
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        3. Qatar
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        4. Kuwait
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        5. South Africa
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        6. Nigeria
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        7. Algeria
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
        8. Rest of MEA
          1. By Product Type
          2. By Route of Administration
          3. By Application
          4. By End User
  13. Competitive Landscape
    1. List of Key Players and Their Types
    2. Global mRNA Vaccine and Therapeutics Company Market Share Analysis, 2024
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  14. Impact of Escalating Geopolitical Tensions on Global mRNA Vaccine and Therapeutics Market
  15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Sanofi
    2. GSK Plc
    3. AstraZeneca
    4. CureVac N.V.
    5. Moderna Inc.
    6. Arcturus Therapeutics
    7. BioNTech SE
    8. Pfizer Inc.
    9. Daiichi Sankyo Company
    10. Silence Therapeutics
    11. Ethris GmbH
    12. Panthera Therapeutics GmbH
    13. Argos Therapeutics Inc.
    14. Gennova Biopharmaceuticals Ltd
    15. Providence Therapeutics
    16. Other Prominent Players
  16. Key Strategic Recommendations
  17. Research Methodology
    1.  Qualitative Research
      1.  Primary & Secondary Research
    2.  Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

List of Figures

 

Figure 1       Global mRNA Vaccine and Therapeutics Segmentation     

Figure 2       Global mRNA Vaccine and Therapeutics Market Value (USD Billion) Chain Analysis         

Figure 3       Company Market Share Analysis, 2024

Figure 4       Global mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 5       Global mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 6       Global mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 7       Global mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 8       Global mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 9       Global mRNA Vaccine and Therapeutics Market Share, By Region, By Value (USD Billion), 2019–2031        

Figure 10     North America mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031        

Figure 11     North America mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031    

Figure 12     North America mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 13     North America mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 14     North America mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 15     North America mRNA Vaccine and Therapeutics Market Share, By Country, By Value (USD Billion), 2019–2031

Figure 16     United States mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031        

Figure 17     United States mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 18     United States mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 19     United States mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 20     United States mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 21     Canada mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 22     Canada mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 23     Canada mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 24     Canada mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 25     Canada mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 26     Europe mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 27     Europe mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 28     Europe mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 29     Europe mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 30     Europe mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 31     Europe mRNA Vaccine and Therapeutics Market Share, By Country, By Value (USD Billion), 2019–2031        

Figure 32     Germany mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 33     Germany mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 34     Germany mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 35     Germany mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 36     Germany mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 37     United Kingdom mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031        

Figure 38     United Kingdom mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031    

Figure 39     United Kingdom mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 40     United Kingdom mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 41     United Kingdom mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 42     Italy mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 43     Italy mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 44     Italy mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 45     Italy mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 46     Italy mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031        

Figure 47     France mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 48     France mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 49     France mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 50     France mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 51     France mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 52     Spain mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 53     Spain mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 54     Spain mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 55     Spain mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 56     Spain mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031        

Figure 57     Belgium mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 58     Belgium mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 59     Belgium mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 60     Belgium mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 61     Belgium mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 62     Russia mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 63     Russia mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 64     Russia mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 65     Russia mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 66     Russia mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 67     The Netherlands mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031    

Figure 68     The Netherlands mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 69     The Netherlands mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031    

Figure 70     The Netherlands mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 71     Rest of Europe mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031        

Figure 72     Rest of Europe mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031    

Figure 73     Rest of Europe mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 74     Rest of Europe mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 75     Rest of Europe mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 76     Asia Pacific mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 77     Asia Pacific mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 78     Asia Pacific mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 79     Asia Pacific mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 80     Asia Pacific mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 81     Asia Pacific mRNA Vaccine and Therapeutics Market Share, By Country, By Value (USD Billion), 2019–2031

Figure 82     China mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 83     China mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 84     China mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 85     China mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 86     China mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031        

Figure 87     India mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 88     India mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 89     India mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 90     India mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 91     India mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031        

Figure 92     Japan mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 93     Japan mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 94     Japan mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 95     Japan mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 96     Japan mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031        

Figure 97     South Korea mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 98     South Korea mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 99     South Korea mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 100   South Korea mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 101   South Korea mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 102   Australia & New Zealand mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031

Figure 103   Australia & New Zealand mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031  

Figure 104   Australia & New Zealand mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031      

Figure 105   Australia & New Zealand mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031     

Figure 106   Australia & New Zealand mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031     

Figure 107   Indonesia mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 108   Indonesia mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 109   Indonesia mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 110   Indonesia mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 111   Indonesia mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 112   Malaysia mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 113   Malaysia mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 114   Malaysia mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 115   Malaysia mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 116   Malaysia mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 117   Singapore mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 118   Singapore mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 119   Singapore mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 120   Singapore mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 121   Singapore mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 122   Vietnam mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 123   Vietnam mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 124   Vietnam mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 125   Vietnam mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 126   Vietnam mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 127   Rest of APAC mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 128   Rest of APAC mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 129   Rest of APAC mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 130   Rest of APAC mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 131   Rest of APAC mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 132   Latin America mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031        

Figure 133   Latin America mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 134   Latin America mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 135   Latin America mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 136   Latin America mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 137   Latin America mRNA Vaccine and Therapeutics Market Share, By Country, By Value (USD Billion), 2019–2031

Figure 138   Brazil mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 139   Brazil mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 140   Brazil mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 141   Brazil mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 142   Brazil mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031        

Figure 143   Mexico mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 144   Mexico mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 145   Mexico mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 146   Mexico mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 147   Mexico mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 148   Argentina mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 149   Argentina mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 150   Argentina mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 151   Argentina mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 152   Argentina mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 153   Peru mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 154   Peru mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 155   Peru mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 156   Peru mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 157   Peru mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031        

Figure 158   Rest of LATAM mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031        

Figure 159   Rest of LATAM mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031    

Figure 160   Rest of LATAM mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 161   Rest of LATAM mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 162   Rest of LATAM mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 163   Middle East and Africa mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031

Figure 164   Middle East and Africa mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031     

Figure 165   Middle East and Africa mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 166   Middle East and Africa mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031     

Figure 167   Middle East and Africa mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031     

Figure 168   Middle East and Africa mRNA Vaccine and Therapeutics Market Share, By Country, By Value (USD Billion), 2019–2031    

Figure 169   Saudi Arabia mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 170   Saudi Arabia mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 171   Saudi Arabia mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 172   Saudi Arabia mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 173   Saudi Arabia mRNA Vaccine and Therapeutics Market Share, By Distribution Form, By Value (USD Billion), 2019–2031    

Figure 174   UAE mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 175   UAE mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 176   UAE mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 177   UAE mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031        

Figure 178   UAE mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031        

Figure 179   Qatar mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 180   Qatar mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 181   Qatar mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 182   Qatar mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 183   Qatar mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031        

Figure 184   Kuwait mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 185   Kuwait mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 186   Kuwait mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031    

Figure 187   Kuwait mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 188   Kuwait mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 189   South Africa mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 190   South Africa mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 191   South Africa mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 192   South Africa mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 193   South Africa mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 194   Nigeria mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 195   Nigeria mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 196   Nigeria mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 197   Nigeria mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 198   Nigeria mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 199   Algeria mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 200   Algeria mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 201   Algeria mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 202   Algeria mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 203   Algeria mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031

Figure 204   Rest of MEA mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Figure 205   Rest of MEA mRNA Vaccine and Therapeutics Market Share, By Product Type, By Value (USD Billion), 2019–2031

Figure 206   Rest of MEA mRNA Vaccine and Therapeutics Market Share, By Route of Administration, By Value (USD Billion), 2019–2031

Figure 207   Rest of MEA mRNA Vaccine and Therapeutics Market Share, By Application, By Value (USD Billion), 2019–2031

Figure 208   Rest of MEA mRNA Vaccine and Therapeutics Market Share, By End User, By Value (USD Billion), 2019–2031         

 

List of Tables

 

Table 1        Global mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 2        Global mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 3        Global mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 4        Global mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 5        Global mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 6        Global mRNA Vaccine and Therapeutics Market Size, By Region, By Value (USD Billion), 2019–2031        

Table 7        North America mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031        

Table 8        North America mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 9        North America mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 10      North America mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 11      North America mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 12      North America mRNA Vaccine and Therapeutics Market Size, By Country, By Value (USD Billion), 2019–2031

Table 13      United States mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031        

Table 14      United States mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 15      United States mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 16      United States mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 17      United States mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 18      Canada mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 19      Canada mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 20      Canada mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 21      Canada mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 22      Canada mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 23      Europe mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 24      Europe mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 25      Europe mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 26      Europe mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 27      Europe mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 28      Europe mRNA Vaccine and Therapeutics Market Size, By Country, By Value (USD Billion), 2019–2031        

Table 29      Germany mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 30      Germany mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 31      Germany mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 32      Germany mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 33      Germany mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 34      United Kingdom mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031        

Table 35      United Kingdom mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031    

Table 36      United Kingdom mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 37      United Kingdom mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 38      United Kingdom mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 39      Italy mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 40      Italy mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 41      Italy mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 42      Italy mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031        

Table 43      Italy mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 44      France mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 45      France mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 46      France mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 47      France mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 48      France mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 49      Spain mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 50      Spain mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 51      Spain mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 52      Spain mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031        

Table 53      Spain mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 54      Belgium mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 55      Belgium mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 56      Belgium mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 57      Belgium mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 58      Belgium mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 59      Russia mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 60      Russia mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 61      Russia mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 62      Russia mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 63      Russia mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 64      The Netherlands mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031    

Table 65      The Netherlands mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 66      The Netherlands mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 67      The Netherlands mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 68      Rest of Europe mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031        

Table 69      Rest of Europe mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 70      Rest of Europe mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 71      Rest of Europe mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 72      Rest of Europe mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 73      Asia Pacific mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 74      Asia Pacific mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 75      Asia Pacific mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 76      Asia Pacific mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 77      Asia Pacific mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 78      Asia Pacific mRNA Vaccine and Therapeutics Market Size, By Country, By Value (USD Billion), 2019–2031

Table 79      China mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 80      China mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 81      China mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 82      China mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031        

Table 83      China mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 84      India mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 85      India mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 86      India mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 87      India mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031        

Table 88      India mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 89      Japan mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 90      Japan mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 91      Japan mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 92      Japan mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031        

Table 93      Japan mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 94      South Korea mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 95      South Korea mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 96      South Korea mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 97      South Korea mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 98      South Korea mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 99      Australia & New Zealand mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031

Table 100    Australia & New Zealand mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031     

Table 101    Australia & New Zealand mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031      

Table 102    Australia & New Zealand mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031     

Table 103    Australia & New Zealand mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031     

Table 104    Indonesia mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 105    Indonesia mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 106    Indonesia mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 107    Indonesia mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 108    Indonesia mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 109    Malaysia mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 110    Malaysia mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 111    Malaysia mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 112    Malaysia mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 113    Malaysia mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 114    Singapore mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 115    Singapore mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 116    Singapore mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 117    Singapore mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 118    Singapore mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 119    Vietnam mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 120    Vietnam mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 121    Vietnam mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 122    Vietnam mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 123    Vietnam mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 124    Rest of APAC mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 125    Rest of APAC mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 126    Rest of APAC mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 127    Rest of APAC mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 128    Rest of APAC mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 129    Latin America mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031        

Table 130    Latin America mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 131    Latin America mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 132    Latin America mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 133    Latin America mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 134    Latin America mRNA Vaccine and Therapeutics Market Size, By Country, By Value (USD Billion), 2019–2031

Table 135    Brazil mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 136    Brazil mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 137    Brazil mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 138    Brazil mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031        

Table 139    Brazil mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 140    Mexico mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 141    Mexico mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 142    Mexico mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 143    Mexico mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 144    Mexico mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 145    Argentina mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 146    Argentina mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 147    Argentina mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 148    Argentina mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 149    Argentina mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 150    Peru mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 151    Peru mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 152    Peru mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 153    Peru mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031        

Table 154    Peru mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 155    Rest of LATAM mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031        

Table 156    Rest of LATAM mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 157    Rest of LATAM mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 158    Rest of LATAM mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 159    Rest of LATAM mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 160    Middle East and Africa mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031

Table 161    Middle East and Africa mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031     

Table 162    Middle East and Africa mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 163    Middle East and Africa mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031     

Table 164    Middle East and Africa mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031    

Table 165    Middle East and Africa mRNA Vaccine and Therapeutics Market Size, By Country, By Value (USD Billion), 2019–2031    

Table 166    Saudi Arabia mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 167    Saudi Arabia mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 168    Saudi Arabia mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 169    Saudi Arabia mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 170    Saudi Arabia mRNA Vaccine and Therapeutics Market Size, By Distribution Form, By Value (USD Billion), 2019–2031    

Table 171    UAE mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 172    UAE mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 173    UAE mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 174    UAE mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031        

Table 175    UAE mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 176    Qatar mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 177    Qatar mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 178    Qatar mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 179    Qatar mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031        

Table 180    Qatar mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 181    Kuwait mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 182    Kuwait mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 183    Kuwait mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 184    Kuwait mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 185    Kuwait mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 186    South Africa mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 187    South Africa mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 188    South Africa mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 189    South Africa mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 190    South Africa mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031

Table 191    Nigeria mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 192    Nigeria mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 193    Nigeria mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 194    Nigeria mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 195    Nigeria mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 196    Algeria mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 197    Algeria mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 198    Algeria mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031    

Table 199    Algeria mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2031

Table 200    Algeria mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031        

Table 201    Rest of MEA mRNA Vaccine and Therapeutics Market Size, By Value (USD Billion), 2019–2031 

Table 202    Rest of MEA mRNA Vaccine and Therapeutics Market Size, By Product Type, By Value (USD Billion), 2019–2031

Table 203    Rest of MEA mRNA Vaccine and Therapeutics Market Size, By Route of Administration, By Value (USD Billion), 2019–2031

Table 204    Rest of MEA mRNA Vaccine and Therapeutics Market Size, By Application, By Value (USD Billion), 2019–2030 Table 205    Rest of MEA mRNA Vaccine and Therapeutics Market Size, By End User, By Value (USD Billion), 2019–2031   

Table 206    Sanofi Company Overview

Table 207    Sanofi Financial Overview

Table 208    GSK Plc Company Overview

Table 209    GSK Plc Financial Overview

Table 210    AstraZeneca Company Overview

Table 211    AstraZeneca Financial Overview

Table 212    CureVac N.V. Company Overview

Table 213    CureVac N.V. Financial Overview

Table 214    Moderna Inc. Company Overview

Table 215    Moderna Inc. Financial Overview

Table 216    Arcturus Therapeutics Company Overview

Table 217    Arcturus Therapeutics Financial Overview

Table 218    BioNTech SE Company Overview

Table 219    BioNTech SE Financial Overview

Table 220    Pfizer Inc. Company Overview

Table 221    Pfizer Inc. Financial Overview

Table 222    Daiichi Sankyo Company: Company Overview

Table 223    Daiichi Sankyo Company Financial Overview

Table 224    Silence Therapeutics Company Overview

Table 225    Silence Therapeutics Financial Overview

Table 226    Ethris GmbH Company Overview

Table 227    Ethris GmbH Financial Overview

Table 228    Panthera Therapeutics GmbH Company Overview

Table 229    Panthera Therapeutics GmbH Financial Overview

Table 230    Argos Therapeutics Inc. Company Overview

Table 231    Argos Therapeutics Inc. Financial Overview

Table 232    Gennova Biopharmaceuticals Ltd Company Overview

Table 233    Gennova Biopharmaceuticals Ltd Financial Overview

Table 234    Providence Therapeutics Company Overview

Table 235    Providence Therapeutics Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Global mRNA Vaccine and Therapeutics Market size was estimated at USD 13.36 billion in 2024.
Ans: During the forecast period between 2025 and 2031, Global mRNA Vaccine and Therapeutics Market size is expected to grow at a CAGR of 15.5% reaching a value of USD 36.64 billion by 2031.
Ans: Major factors driving the growth of Global mRNA Vaccine and Therapeutics Market include the rising demand for gene & cell therapies, increasing approvals for viral vector-based drugs & vaccines, and growing number of clinical trials.
Ans: Key players in Global mRNA Vaccine and Therapeutics Market include Sanofi, GSK Plc., AstraZeneca, CureVac N.V., Moderna Inc., Arcturus Therapeutics, BioNTech SE, Pfizer Inc., Daiichi Sankyo Company, Silence Therapeutics, Ethris GmbH, Panthera Therapeutics GmbH, Argos Therapeutics Inc., Gennova Biopharmaceuticals Ltd, and Providence Therapeutics.
Ans: The hospital & clinic segment holds the largest market share of Global mRNA Vaccine and Therapeutics Market by end user.
Ans: North America is expected to grow at the fastest CAGR in the Global mRNA Vaccine and Therapeutics Market during the forecast period between 2025 and 2031. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1765011295)
}